Stock Report

All about this stock under one free report Last Updated: 16-Jun-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Beta Drugs Ltd.

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: BETA

₹1,889.90

up-down-arrow ₹54.30 (2.96%)

As on 16-Jun-2026 11:34IST

Market cap

info icon

₹2,073 Cr

Revenue (TTM)

info icon

₹362 Cr

P/E Ratio

info icon

50

P/B Ratio

info icon

7.1

Div. Yield

info icon

0 %

Beta Drugs Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
loading...
loading...
NSE
loading...
loading...
loading...
loading...
NSE
loading...
loading...

Stock Range

Today’s Range

Low: 1,850.00 High: 1,915.00

52 Week Range

Low: 990.10 High: 2,000.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹42 Cr

  • ROEROE information

    24 %

  • ROCEROCE information

    25.2 %

  • Industry P/EIndustry P/E information

    39.7

  • EV/EBITDAEV/EBITDA information

    24.1

  • Debt to EquityDebt to Equity information

    0.7

  • Book ValueBook Value information

    ₹195.2

  • EPSEPS information

    ₹42

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    11,085,872

10 Years Aggregate

CFO

₹168.68 Cr

EBITDA

₹304.64 Cr

Net Profit

₹175.75 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Beta Drugs
22.0 48.6 69.3 4.4 35.7 46.9 --
BSE Healthcare
8.1 -0.5 9.8 6.7 23.6 13.1 12.1
As on 16-Jun-2026
Company
2025
2024
2023
2022
2021
2020
2019
Beta Drugs
-18.0 40.8 107.0 10.9 436.7 58.9 -0.8
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...
Quarterly Annual

*All values are in (₹ Cr)

loading...
Annual

*All values are in (₹ Cr)

loading...
Annual

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
 Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Beta Drugs
1,889.9 2,073.1 362.4 42.4 -- 24 50 7.1
Acutaas Chemicals
2,989.4 25,127.1 1,339.4 356.4 33.2 23.2 70.5 15.2
Cohance Lifesciences
432.6 16,381.5 2,268.6 150.1 10.6 5.4 91.4 4.2
Granules India
754.2 18,557.5 5,365.6 595.0 16.6 13.3 31.2 3.6
Jubilant Pharmova
983.5 15,723.4 8,279.6 397.8 9.9 6.4 39.5 2.2
Onesource Specialty Pharma
1,605.8 18,737.1 1,421.6 -73.8 1.8 -1.1 -- 3.2
Piramal Pharma
163.3 22,186.9 8,869.1 -383.1 1.0 -4.2 -- 2.7
Rubicon Research
1,324.2 22,806.3 1,284.3 134.4 -- 30.7 92.4 17.7
Syngene Intl
454.1 18,239.8 3,738.7 316.7 12.5 7.5 57.6 3.8
Wockhardt
1,912.5 31,360.2 3,373.0 199.0 12.6 5.9 147.2 6.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Beta Drugs

--

  • Incorporated

    2005

  • Chairman

    Rahul Batra

  • Managing Director

    Rahul Batra

  • Headquarters

    Baddi, Himachal Pradesh

  • Website

    www.betadrugslimited.com

Looking for more details about Beta Drugs Ltd.’s IPO? Explore our IPO Details page.

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

Announcements

View Announcements

No News & Announcements are available.

FAQs for Beta Drugs

The share price of Beta Drugs Ltd is ₹1,889.90 (NSE) as of 16-Jun-2026 11:34 IST. Beta Drugs Ltd has given a return of 35.68% in the last 3 years.

The P/E ratio of Beta Drugs Ltd is 49.97 times as on 16-Jun-2026, a 26 premium to its peers’ median range of 39.70 times.
The P/B ratio of Beta Drugs Ltd is 7.05 times as on 16-Jun-2026, a 90 premium to its peers’ median range of 3.72 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
45.35
9.76
2024
31.00
7.55
2023
19.62
4.90
2022
21.90
5.89
2021
9.84
1.68

The 52-week high and low of Beta Drugs Ltd are Rs 2,000.00 and Rs 990.10 as of 16-Jun-2026.

Beta Drugs Ltd has a market capitalisation of ₹ 2,073 Cr as on 16-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Beta Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.